ArticleThe Journal of investigative dermatology2015
Somatic Activating RAS Mutations Cause Vascular Tumors Including Pyogenic Granuloma.
Article in The Journal of investigative dermatology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed.
- Efficacy of Nd-YAG laser for treatment of pyogenic granuloma on the fingers and toes.Lasers in medical science · 2019Trial
- Association between 8-OHdG Levels and Eosinophil Counts in Chronic Rhinosinusitis with Nasal Polyps.International archives of otorhinolaryngology · 2026Article
- RAS Pathway Mutations and Therapeutics in Vascular Anomalies.Pediatric blood & cancer · 2025Review
- Age, Sex, and Anatomical Location Patterns in Cutaneous Pyogenic Granuloma Cases.JAMA dermatology · 2025Article
- Congenital Vascular and Lymphatic Diseases.Circulation research · 2024Review
- Oral Pyogenic Granuloma: A Narrative Review.International journal of molecular sciences · 2023Review
- Kaposiform lymphangiomatosis: Diagnosis, pathogenesis, and treatment.Pediatric blood & cancer · 2023Review
- Dominant ARF3 variants disrupt Golgi integrity and cause a neurodevelopmental disorder recapitulated in zebrafish.Nature communications · 2022Article
- The Genetic Architecture of Vascular Anomalies: Current Data and Future Therapeutic Perspectives Correlated with Molecular Mechanisms.International journal of molecular sciences · 2022Review
- NRASAngiogenesis · 2022Article
- Recurrent Alterations in the MAPK pathway in Sporadic Pyogenic Granuloma of Childhood.Acta dermato-venereologica · 2022Article
- Cutaneous and hepatic vascular lesions due to a recurrent somaticHGG advances · 2021Article
- NOGOB receptor-mediated RAS signaling pathway is a target for suppressing proliferating hemangioma.JCI insight · 2021Article
- GNA14, GNA11, and GNAQ Mutations Are Frequent in Benign but Not Malignant Cutaneous Vascular Tumors.Frontiers in genetics · 2021Article
- New and Emerging Targeted Therapies for Vascular Malformations.American journal of clinical dermatology · 2020Review
- [Pyogenic granuloma with satellitosis].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2020Article
- Cell Populations Expressing Stemness-Associated Markers in Vascular Anomalies.Frontiers in surgery · 2020Review
- A somatic activating NRAS variant associated with kaposiform lymphangiomatosis.Genetics in medicine : official journal of the American College of Medical Genetics · 2019Article
- Genetic investigation of childhood vascular tumor biology reveals pathways for therapeutic intervention.F1000Research · 2019Review
- Vascular Anomalies: From a Clinicohistologic to a Genetic Framework.Plastic and reconstructive surgery · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.